A detailed history of Capital World Investors transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Capital World Investors holds 13,493,852 shares of TMO stock, worth $7.66 Billion. This represents 1.34% of its overall portfolio holdings.

Number of Shares
13,493,852
Previous 12,262,793 10.04%
Holding current value
$7.66 Billion
Previous $6.51 Billion 20.49%
% of portfolio
1.34%
Previous 1.19%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $651 Million - $738 Million
1,231,059 Added 10.04%
13,493,852 $7.84 Billion
Q4 2023

Feb 13, 2024

SELL
$431.41 - $532.94 $212 Million - $262 Million
-492,214 Reduced 3.86%
12,262,793 $6.51 Billion
Q3 2023

Nov 13, 2023

SELL
$498.29 - $574.41 $60.3 Million - $69.6 Million
-121,091 Reduced 0.94%
12,755,007 $6.46 Billion
Q2 2023

Aug 11, 2023

SELL
$508.46 - $591.13 $24.6 Million - $28.6 Million
-48,366 Reduced 0.37%
12,876,098 $6.72 Billion
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $332 Million - $375 Million
-620,777 Reduced 4.58%
12,924,464 $7.45 Billion
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $27.7 Million - $32.7 Million
57,180 Added 0.42%
13,545,241 $7.46 Billion
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $254 Million - $303 Million
-501,558 Reduced 3.59%
13,488,061 $6.84 Billion
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $89.1 Million - $109 Million
-177,932 Reduced 1.26%
13,989,619 $7.6 Billion
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $357 Million - $440 Million
-682,179 Reduced 4.59%
14,167,551 $8.37 Billion
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $21.1 Million - $24.7 Million
-37,056 Reduced 0.25%
14,849,730 $9.91 Billion
Q3 2021

Nov 15, 2021

BUY
$509.53 - $609.78 $58.4 Million - $69.9 Million
114,582 Added 0.78%
14,886,786 $8.51 Billion
Q2 2021

Aug 16, 2021

SELL
$441.0 - $508.24 $867 Million - $1 Billion
-1,966,990 Reduced 11.75%
14,772,204 $7.45 Billion
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $333 Million - $393 Million
757,674 Added 4.74%
16,739,194 $7.64 Billion
Q4 2020

Feb 12, 2021

SELL
$435.06 - $527.66 $18.1 Million - $21.9 Million
-41,513 Reduced 0.26%
15,981,520 $7.44 Billion
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $197 Million - $242 Million
-548,434 Reduced 3.31%
16,023,033 $7.07 Billion
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $69.7 Million - $91.8 Million
-253,259 Reduced 1.51%
16,571,467 $6 Billion
Q1 2020

May 15, 2020

BUY
$255.3 - $340.05 $317 Million - $422 Million
1,242,140 Added 7.97%
16,824,726 $4.77 Billion
Q4 2019

Feb 18, 2020

SELL
$271.93 - $328.04 $10.7 Million - $12.9 Million
-39,392 Reduced 0.25%
15,582,586 $5.06 Billion
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $2.38 Million - $2.71 Million
8,880 Added 0.06%
15,621,978 $4.55 Billion
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $19.6 Million - $22.5 Million
76,074 Added 0.49%
15,613,098 $4.59 Billion
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $116 Million - $150 Million
547,242 Added 3.65%
15,537,024 $4.25 Billion
Q4 2018

Feb 14, 2019

SELL
$208.47 - $251.98 $88.1 Million - $106 Million
-422,460 Reduced 2.74%
14,989,782 $3.35 Billion
Q3 2018

Nov 14, 2018

BUY
$205.57 - $244.32 $510 Million - $607 Million
2,482,783 Added 19.2%
15,412,242 $3.76 Billion
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $64.5 Million - $69.7 Million
317,680 Added 2.52%
12,929,459 $2.68 Billion
Q1 2018

May 15, 2018

SELL
$192.98 - $224.11 $53.6 Million - $62.3 Million
-277,943 Reduced 2.16%
12,611,779 $2.6 Billion
Q4 2017

Feb 14, 2018

BUY
$182.03 - $200.37 $1.97 Million - $2.17 Million
10,844 Added 0.08%
12,889,722 $2.45 Billion
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $2.21 Billion - $2.5 Billion
12,878,878
12,878,878 $2.44 Billion

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $223B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.